Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The EMN Trial Office is the operational hub of the European Myeloma Network (EMN), a leading non-profit foundation dedicated to advancing research and treatment for multiple myeloma and related plasma cell disorders. Based in Turin, Italy, the office specializes in the management and coordination of international, multicenter clinical trials across Europe. It provides a comprehensive range of services, including protocol development, regulatory affairs, pharmacovigilance, and data management. By bridging the gap between academic research and the pharmaceutical industry, the EMN Trial Office facilitates the development of innovative therapies such as monoclonal antibodies, bispecifics, and CAR-T cell therapies. Through its extensive network of European trial sites, the organization plays a pivotal role in establishing new standards of care for hematological malignancies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EMN Trial Office.